Edgewise Therapeutics (EWTX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Edgewise Therapeutics, as the data feed reports them.

Analysts' mean target, 12 analysts
$55.42
31.8% above the price

The 12 analysts reported by the data feed have a mean price target for Edgewise Therapeutics of $55.42, 31.8% above the $42.04 price (range $36.00–$85.00). 16.29% of the float was sold short as of Oct 30, 2026. Institutions hold 116.8% of the shares and insiders 0.5%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$55.42+31.8% vs price
Analysts
12
Short interest
16.29%of float, Oct 30, 2026
Short ratio
9.14 days
Institutions
116.8%
Insiders
0.50%
Beta
0.4

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

12 analysts covering Edgewise Therapeutics, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $42.04.

Analysts' price targets for Edgewise Therapeutics
Mean price target$55.4231.8% above the price (+31.8%)
Median price target$53.5027.3% above the price (+27.3%)
Highest target$85.00102.2% above the price (+102.2%)
Lowest target$36.0014.4% below the price (−14.4%)
Analysts with a target12

Ratings this month · 13 analysts

Strong buy 3(23%)Buy 9(69%)Hold 1(8%)
Analysts' ratings of Edgewise Therapeutics this month, by rating
RatingAnalystsShare
Strong buy323%
Buy969%
Hold18%
Sell00%
Strong sell00%

The feed averages these to 1.38 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Edgewise Therapeutics

Ownership of Edgewise Therapeutics
Held by institutions116.8%346 institutions; percent of shares outstanding
Held by institutions, of the float117.4%
Held by insiders0.50%percent of shares outstanding
Shares outstanding109.48M
Float75.14Mshares available to trade
Insiders' net purchases, six months+54.63K8 purchases (302.5K shares), 7 sales (247.87K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Edgewise Therapeutics
Shares short12.7Mas of Oct 30, 2026
Percent of float16.29%shares short ÷ float
Percent of shares outstanding11.60%shares short ÷ shares outstanding
Short ratio (days to cover)9.14shares short ÷ average daily volume

Edgewise Therapeutics short interest from FINRA, with its history

Trading figures

Trading figures for Edgewise Therapeutics
Beta0.4movement against the market; 1 moves with it
52-week high$48.78
52-week low$19.76
Average volume, 3 months1.55Mshares a day
Average volume, 10 days2.13Mshares a day

Questions and answers

What is the analysts' price target for Edgewise Therapeutics (EWTX)?

As reported by the data feed, the mean price target of the 12 analysts covering Edgewise Therapeutics is $55.42, 31.8% above the latest price of $42.04. The highest target is $85.00 and the lowest $36.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Edgewise Therapeutics stock?

Of the 13 ratings the data feed reports for the current month, 3 are strong buy, 9 buy, 1 hold, 0 sell and 0 strong sell.

How many Edgewise Therapeutics shares are sold short?

As reported by the data feed, 12.7M shares were sold short, 16.29% of the float as of Oct 30, 2026. At the average daily volume that is 9.14 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Edgewise Therapeutics stock?

As reported by the data feed, institutions hold 116.8% of the shares (346 institutions) and insiders 0.5%. There are 109.48M shares outstanding, of which 75.14M are in the float.

How much does Edgewise Therapeutics stock move with the market?

Its beta, as reported by the data feed, is 0.4: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $19.76 and $48.78.

Cite this page

Funkfolio, “Edgewise Therapeutics (EWTX) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/EWTX/statistics

Underlying data: Yahoo Finance.